Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Burn injury leads to hypovolemic then distributive shock. Fluid resuscitation remains the cornerstone of initial treatment of burn shock. However, fluid rescucitation can lead to fluid overload, which manifests most notably as lung edema.
The peptide NT-pro-BNP, a biomarker of cardiac congestion secreted by the myocardium, as well as plasma CD146, an endothelial factor involved in angiogenesis and a marker of vascular congestion, may help identifying patients with risk of pulmonary edema and hypoxia .
Our hypothesis is that these biomarkers may predict the occurence of pulmonary edema in severe burns patients.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Lung edema | Extravascular lung water (EVLW) > 10 mL/Kg as measured by transpulmonary thermodilution (TPTD) | During the first 7 days of admission |
| Measure | Description | Time Frame |
|---|---|---|
| Hypoxemia | PaO2/FiO2 ratio of <200 | During the first 7 days of admission for mechanically-ventilated patients |
| Hypercapnia | PaCO2> 45 mmHg |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Severely ill burn patients admitted to a tertiary referral burn center
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Sabri Soussi, MD | Contact | 0613064542 | +33 | sabri.soussi@gmail.com |
| Matthieu Legrand, MD, PhD | Contact | 0685104235 | +33 | matthieu.m.legrand@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Sabri Soussi, MD | Saint-Louis Hospital, Paris, France | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sabri SOUSSI | Recruiting | Paris | Île-de-France Region | 75010 | France |
Not provided
| Label | URL |
|---|---|
| Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure | View source |
| Natriuretic peptide type B in burn intensive care | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002056 | Burns |
| D004487 | Edema |
| D011654 | Pulmonary Edema |
| ID | Term |
|---|---|
| D014947 | Wounds and Injuries |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D008171 | Lung Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Serum bank : 1 sample (5 ml of blood): on admission and from day 1 to day 7 of admission.
| During the first 7 days of admission for mechanically-ventilated patients |
| Corrected minute ventilation > 10L/min | Minute ventilation × partial [Paco2]/40) > 10L/min | During the first 7 days of admission for mechanically-ventilated patients |
| Multiple organ dysfunction syndrome (MODS) | Sequential Organ Failure Assessment score (SOFA) ≥ 8 | During the first 7 days of admission |
| 28-day mortality | 28 days |
| 90-day mortality | 90 days |
| Length of stay in the ICU | until 90 days of hospitalization |
| Plasma Levels of Soluble CD146 Reflect the Severity of Pulmonary Congestion Better Than Brain Natriuretic Peptide in Acute Coronary Syndrome |
| View source |
| D012140 | Respiratory Tract Diseases |